RC
IOSP icon

RegentAtlantic Capital’s Innospec IOSP Stock Holding History

RegentAtlantic Capital’s Portfolio IOSP Stock Details IOSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-160
Closed -$6.83K – 613
2014
Q4 		$6.83K Buy
+160
New +$6.56K ﹤0.01% 966

Other funds holding IOSP

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HCM
Huber Capital Management El Segundo, California $679M AUM 25.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

RegentAtlantic Capital's IOSP Position: Q1 2015 in Review

RegentAtlantic Capital sold out of Innospec (IOSP) in Q1 2015, closing a stake of 160 shares — an estimated $6.83K sold.

RegentAtlantic Capital first reported a position in IOSP in Q4 2014 and held it in 1 quarter. The position peaked at $6.83K in Q4 2014. 138 funds tracked by Wall St. Rank hold IOSP as of Q1 2015.

  • RegentAtlantic Capital reported no remaining Innospec position as of Q1 2015 after selling out during the quarter.
  • RegentAtlantic Capital sold 160 Innospec shares in Q1 2015, an estimated $6.83K.
  • RegentAtlantic Capital first reported a position in Innospec in Q4 2014 and held it in 1 quarter.
  • RegentAtlantic Capital's Innospec position peaked at $6.83K in Q4 2014.
  • 138 funds tracked by Wall St. Rank held Innospec as of Q1 2015.

Based on RegentAtlantic Capital's 13F filing for Q1 2015, filed 27 Apr 2015.